These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32256050)

  • 21. Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway.
    Wang EL; Zhang JJ; Luo FM; Fu MY; Li D; Peng J; Liu B
    Life Sci; 2023 Sep; 328():121879. PubMed ID: 37355224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets.
    Wang Y; Duo D; Yan Y; He R; Wu X
    Biomed Pharmacother; 2020 Oct; 130():110560. PubMed ID: 34321157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition.
    Li X; Li H; Feng B; Chen X; Chen T; Lu J; Xie H; Su N; Chen H; Lou C; Zhuang R; Chen X; Jin S; Hao Y
    Biomed Pharmacother; 2024 Aug; 177():117023. PubMed ID: 38908199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Happé CM; de Raaf MA; Rol N; Schalij I; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; de Man FS; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1088-97. PubMed ID: 27036867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
    Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
    Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
    Goto I; Dohi K; Ogihara Y; Okamoto R; Yamada N; Mitani Y; Ito M
    Circ J; 2016; 80(4):989-97. PubMed ID: 26924211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
    Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q
    Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Eur J Pharmacol; 2019 Nov; 863():172673. PubMed ID: 31542480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
    Huang J; Lu W; Ouyang H; Chen Y; Zhang C; Luo X; Li M; Shu J; Zheng Q; Chen H; Chen J; Tang H; Sun D; Yuan JX; Yang K; Wang J
    Am J Respir Cell Mol Biol; 2020 Jan; 62(1):49-60. PubMed ID: 31211918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition.
    Shi R; Zhu D; Wei Z; Fu N; Wang C; Liu L; Zhang H; Liang Y; Xing J; Wang X; Wang Y
    Life Sci; 2018 Aug; 207():442-450. PubMed ID: 29969608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization.
    Yu M; Wu X; Peng L; Yang M; Zhou H; Xu J; Wang J; Wang H; Xie W; Kong H
    Oxid Med Cell Longev; 2022; 2022():6526036. PubMed ID: 36071873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baicalin attenuates pulmonary vascular remodeling by inhibiting calpain-1 mediated endothelial-to-mesenchymal transition.
    Jiang HX; Wang XD; Wang HX; Liu T
    Heliyon; 2023 Dec; 9(12):e23076. PubMed ID: 38144352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.